EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Cancer of the vulva: 2025 update

Alexander B Olawaiye, Mauricio A Cuello, Sushil Beriwal, Linda J Rogers

International Journal of Gynecology & Obstetrics · 2025-09 · 171 (S1) · 36-47

DOI: 10.1002/ijgo.70390 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 30.07.2025. Verfasst von Alexander B Olawaiye und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsb…. Hauptthemen laut MEDLINE: Vulvar Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vulvar cancer is an uncommon gynecological malignancy primarily affecting postmenopausal women. No specific screening exists and the most effective strategy to reduce the incidence of vulvar cancer is the opportune treatment of predisposing and preneoplastic lesions associated with its development. Although vulvar cancer may be asymptomatic, most women present with vulvar pruritus or pain or have noticed a lump or ulcer. Therefore, any suspicious vulvar lesion should be biopsied to exclude invasion. Once established, the most common subtype is squamous cell carcinoma. The treatment of vulvar cancer depends primarily on histology, clinical, radiological, or surgical staging. Treatment is predominantly surgical and/or adjuvant radiation therapy, particularly for squamous cell carcinoma, although definitive concurrent chemoradiation is an effective alternative, particularly for advanced tumors. In those cases where vulvar cancer presents with distant metastases, systemic therapy is modeled after cervical cancer, a more common cancer where there is more robust data to guide treatment. Management should be individualized and carried out by a multidisciplinary team in a cancer center experienced in the treatment of these tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vulvar NeoplasmsCarcinoma, Squamous CellFemaleHumansNeoplasm Staging

Stichwörter der Autor:innen

FIGO cancer reportcancer stagingchemotherapydiagnostic imagingradiotherapyrisk factorssurgerytherapyvulvar cancervulvar neoplasms

Autor:innen und Institutionen

  • Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Department of Gynecology, Division of Obstetrics and Gynecology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Department of Radiation Oncology, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
  • Division of Gynecological Oncology, Groote Schuur Hospital/University of Cape Town, Cape Town, South Africa.
  • South African Medical Research Council University of Cape Town Gynecological Cancer Research Centre (SA MRC UCT GCRC), Cape Town, South Africa.

Zitieren

APA

Olawaiye, A. B., Cuello, M. A., Beriwal, S., & Rogers, L. J. (2025). Cancer of the vulva: 2025 update. International Journal of Gynecology & Obstetrics, 171(S1), 36-47. https://doi.org/10.1002/ijgo.70390

Vancouver

Olawaiye AB, Cuello MA, Beriwal S, Rogers LJ. Cancer of the vulva: 2025 update. International Journal of Gynecology & Obstetrics. 2025;171(S1):36-47. doi:10.1002/ijgo.70390

BibTeX
@article{Olawaiye2025,
  author = {Olawaiye, Alexander B and Cuello, Mauricio A and Beriwal, Sushil and Rogers, Linda J},
  title = {Cancer of the vulva: 2025 update},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2025},
  volume = {171},
  number = {S1},
  pages = {36--47},
  doi = {10.1002/ijgo.70390}
}
Kostenlos starten →